The U.S. Food and Drug Administration said on Wednesday it has approved Nuvation Bio's drug for patients with a rare and aggressive form of lung cancer.

Imdelltra significantly reduced the risk of death by 40% versus chemo in small cell lung cancer patients who had tried one line of chemotherapy.

Treatment with tarlatamab led to longer overall survival than chemotherapy among patients with small-cell lung cancer whose disease had progressed during or after platinum-based chemotherapy.

ZL-1310 earns fast track designation in extensive-stage small cell lung cancer after early trial data showed tumor shrinkage in most patients treated.

A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the genes that matter in chemotherapy resistance in small cell lung cancer.

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

IMDELLTRA® (tarlatamab-dlle) U.S. Indication IMDELLTRA ® (tarlatamab-dlle) is indicated for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) with disease ...

Imdelltra is associated with improvement in overall survival compared to local standard-of-care chemotherapy among patients with small cell lung cancer.

The top U.S. health official is calling for all alcoholic beverages to carry a warning label about cancer risk.

Zoom In: The 20 Best Images From Nikon’s Small World Up Close Competition The 50th rendition of the annual competition showcases butterfly wings on the tips of needles and cells from mouse brains.

Study shows that dietary antigens can suppress small intestine carcinogenesis by activating T-cells through Peyer's patches. Adding bovine serum albumin (BSA) or ovalbumin (OVA) to antigen-free ...

The researchers' ambition was to create a nimble, versatile ChatGPT-like AI platform that can perform a broad range of cancer evaluation tasks.